secwatch.observer — SEC 8-K summary
======================================

Issuer:     Corbus Pharmaceuticals Holdings, Inc. (CRBP)
CIK:        0001595097
Form:       8-K
Filed at:   2026-01-12T23:59:59+00:00
Accession:  0001193125-26-009758
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Corbus updates investor presentation; no new material financial or operational data disclosed
--------------------------------------------------------------------------------

- Furnished updated corporate presentation under Item 7.01 Regulation FD.
- Presentation dated January 12, 2026; no specific changes or metrics provided in filing.
- No earnings, guidance, or clinical milestones reported in the exhibit text.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1595097/000119312526009758/0001193125-26-009758-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1595097/000119312526009758/crbp-20260112.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-009758

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer